Drreddys Laboratories reported INR1.46B in Loan Capital for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Ani Pharmaceuticals ANIP:US USD 285.67M 213K
Aurora Cannabis Inc ACB:CN CAD 194.71M 91.36M
Bayer BAYN:GR EUR 33.79B 5.67B
Canopy Growth Corp WEED:CN CAD 833.28M 290.12M
Catalent CTLT:US USD 4.22B 123M
Drreddys Laboratories RDY:US INR 1.46B 338M
Endo International Ordinary Shares ENDP:US USD 1.42M 8.05B
GlaxoSmithKline GSK:LN GBP 17.04B 2.29B
Hikma Pharmaceutical HIK:LN USD 1.14B 279M
Horizon Pharma HZNP:US USD 2.55B 2.3M
Lonza Group LONN:SW CHF 1.55B 393M
Novartis NOVN:VX USD 21.78B 547M
Pacira Pharmaceuticals PCRX:US USD 655.82M 58.18M
Phibro Animal Health PAHC:US USD 460.81M 9.07M
Prestige Brands PBH:US USD 1.43B 14.95M
Richter Gedeon RICHT:HB HUF 12.29B 970M
Teva Pharmaceutical TEVA:IT USD 19.1B 606M